Finland· FI-REL-REL17984
Prilium
A imidapriili product containing imidapril hydrochloride, registered in Finland by Vetoquinol S.A.. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Imidapril hydrochloride is registered in 2 of 19 countries.
Countries holding a registration under ATC QC09AA16 (imidapriili), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Imidapril hydrochloride · ATC QC09AA16
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Imidapril hydrochloride
- Manufacturer
- Vetoquinol S.A.
- Country
- Finland (FI)
- ATC code
- QC09AA16
- ATC class
- Imidapriili
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Imidapril hydrochloride in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTANATRILMylan IRE Healthcare Limited, Dublin
- Japanイミダプリル塩酸塩沢井製薬
- SpainHIPERTENE 10 mg COMPRIMIDOSLaboratorios Bial S.A.
- United KingdomTanatril 10mg tabletsNorthumbria Pharma Ltd
- PolandTanatrilBausch Health Ireland Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Austria · Tanatril
- Czechia · Tanatril
- Spain · Hipertene, Imidapril Dari Pharma
- United Kingdom (Northern Ireland) · Imidapril Northumbria Pharma, Imidapril Northumbria Pharma Ltd
- Poland · Tanatril
- Portugal · Cardipril
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f72ea043-464a-4517-b808-44be2a646afd GET /v1/drugs/f72ea043-464a-4517-b808-44be2a646afd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "jauhe oraaliliuosta varten",
"route": "Suun kautta",
"ddd_unit": null,
"strength": "150 mg",
"atc_label": "Imidapriili",
"ma_number": "17600",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL17984",
"authorised_at": "2003-02-06"
}See everything about imidapril hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.